MORNEAU MICHAEL 4
4 · Viking Therapeutics, Inc. · Filed May 8, 2018
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Tax Payment
Common Stock, par value $0.00001 per share
2018-05-04$4.22/sh−7,616$32,140→ 94,035 total
Footnotes (1)
- [F1]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock.